BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//132.216.98.100//NONSGML kigkonsult.se iCalcreator 2.20.4//
BEGIN:VEVENT
UID:20250626T234847EDT-4624EAeuhM@132.216.98.100
DTSTAMP:20250627T034847Z
DESCRIPTION:Abstract:\n\nThe standard care of cancer therapy is highly depe
 ndent on the cancer type\, stage and patients. Consequently\, for most can
 cers there is only marginal improvements in patient survival rates. Undete
 cted/unremoved cancer during surgery or resistance to chemotherapy\, are m
 ajor causes for a poor prognosis. To tackle these issues\, research in my 
 lab focuses on i) the development of fluorescent chemosensors to predict a
 nticancer drug resistance for personalized medicine\, and ii) the developm
 ent of novel photosensitizers for photodynamic therapy\; some properties i
 nclude: enhanced cancer cell selectivity\, biomolecular targeting (enzymes
 \, DNA)\, and the generation of singlet oxygen without light excitation.\n
 \n \n\nBio:\n\nAndrew Beharry obtained his Ph.D. in chemistry at the Unive
 rsity of Toronto under the supervision of Prof. Andrew Woolley. He then at
 tended Stanford University as a Human Frontiers Science Program Postdoctor
 al Fellow under the supervision of Prof. Eric Kool\, a world leader in nuc
 leic acid chemistry. As a faculty member at the University of Toronto Miss
 issauga at the Department of Chemical and Physical Sciences\, Prof. Beharr
 y runs a multi-disciplinary\, independent research program that employs or
 ganic chemistry\, photochemistry\, biochemistry\, and cell biology\, to de
 velop photoactive molecules for clinical applications. Since 2016\, he has
  conveyed his work at 12 invited talks and has been the recipient of the C
 onnaught New Researcher Award\, the 2021 University of Toronto Mississauga
  Research Prize and 2022 CNC-IUPAC Travel Award. He has received an NSERC 
 Discovery grant and grants from the Cancer Research Society (ranked top fi
 ve young investigators)\, New Frontiers in Research Fund\, Brain Tumour Fo
 undation of Canada and the American Brain Tumour Association.\n
DTSTART:20221129T180000Z
DTEND:20221129T193000Z
LOCATION:Room 10\, Maass Chemistry Building\, CA\, QC\, Montreal\, H3A 0B8\
 , 801 rue Sherbrooke Ouest
SUMMARY:Chemical Society Seminar: - Andrew Beharry- Light-Responsive Probes
 : Guiding Clinician Decision-Making and Destroying Cancer 
URL:/chemistry/channels/event/chemical-society-seminar
 -andrew-beharry-light-responsive-probes-guiding-clinician-decision-making-
 343079
END:VEVENT
END:VCALENDAR